Provenance du réseau au premier degré de Stephen James
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 46 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Stephen James via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President Director/Board Member | |
| DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member President | |
| University of Lund | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Public Communications Contact Chief Executive Officer | |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal General Counsel | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Chief Executive Officer Director of Finance/CFO Director/Board Member | |
| MEDA AB | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| University of Uppsala | College/University | Corporate Officer/Principal Undergraduate Degree | |
| BAXALTA INC | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Executive Officer Chief Operating Officer | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| AVROBIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact | |
| RECIPHARM AB (PUBL) | Biotechnology | Director of Finance/CFO Public Communications Contact | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| XBRANE BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| GENERATION BIO CO. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Harvard Medical School | College/University | Doctorate Degree Graduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Sobi, Inc. | Compliance Officer Corporate Officer/Principal | ||
Ganni A/S
 Ganni A/S Apparel/FootwearConsumer Non-Durables Ganni A/S engages in the wholesale distribution of men's apparel and furnishings. It offers dresses, skirts, lingerie, sunglasses, special picks, knitwear, bags, shorts, tops, and trousers. The company was founded by Nicolaj Reffstrup, Anders Schroll Christiansen and Frans Grønholdt Truelsen in 2000 and is headquartered in Copenhagen, Denmark. | Apparel/Footwear | Director of Finance/CFO | |
| Arden Regulatory Clinical & Medical Consulting Ltd. | Director/Board Member | ||
The British United Provident Association Ltd.
 The British United Provident Association Ltd. Life/Health InsuranceFinance The British United Provident Association Ltd. provides healthcare products and services. It offers health, dental and travel insurance, optical and audiology, and care homes. The company was founded on April 3, 1947 and is headquartered in London, the United Kingdom. | Life/Health Insurance | Sales & Marketing | |
| NET INSIGHT AB | Telecommunications Equipment | Director of Finance/CFO | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal | |
| INFLARX N.V. | Biotechnology | Director/Board Member | |
| Jane Goddall Institute Belgium | Director/Board Member | ||
| Ohmeda Pharmaceuticals | Corporate Officer/Principal | ||
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
Sanofi AB
 Sanofi AB Medical DistributorsDistribution Services Part of Sanofi, Sanofi AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company's description states that it is an international pharmaceutical company. | Medical Distributors | Corporate Officer/Principal | |
Takeda AS
 Takeda AS Pharmaceuticals: MajorHealth Technology Takeda AS operates as a pharmaceutical company. It manufactures and distributes generic medicines. The firm offers therapeutics in the areas such as cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. The company founded by Morten Nyegaard in 1874 and is headquartered in Asker, Norway. | Pharmaceuticals: Major | Human Resources Officer | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
| ADVICENNE | Pharmaceuticals: Generic | Corporate Officer/Principal | |
| FREELINE THERAPEUTICS HOLDINGS PLC | Biotechnology | Chief Executive Officer | |
| Ullevaal School of Bioengineering | College/University | Undergraduate Degree | |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Alnylam Germany GmbH
 Alnylam Germany GmbH BiotechnologyHealth Technology Part of Alnylam Pharmaceuticals, Inc., Alnylam Germany GmbH is a company that is leading the translation of RNA Interference (RNAi) into a completely innovative class of medicines, which they believe have the potential to transform the lives of patients with genetic and rare diseases. The company is based in Munich, Germany. The CEOs of the company are David Ronald Jones, Hannes Schmeil, Theresa Marie Heggie. The text in the company's description is in German, but it appears to emphasize the importance of clinical trials in developing new medicines and highlights the company's use of RNAi technology to help patients with limited treatment options. | Biotechnology | Chief Executive Officer | |
| CAMURUS AB | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Suède | 20 |
| Etats-Unis | 15 |
| Royaume-Uni | 7 |
| Danemark | 4 |
| Allemagne | 4 |
Sectorielle
| Health Technology | 33 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Finance | 3 |
| Consumer Non-Durables | 2 |
Opérationnelle
| Director/Board Member | 149 |
| Corporate Officer/Principal | 87 |
| Independent Dir/Board Member | 59 |
| Chairman | 39 |
| Chief Executive Officer | 33 |
Relations les plus connectées
| Insiders | |
|---|---|
| Sven Håkan Björklund | 46 |
| Bo Jesper Hansen | 34 |
| Jeff Jonas | 21 |
| Guido Oelkers | 19 |
| Alan Henry Raffensperger | 17 |
| Lena Elisabeth Svanberg | 16 |
| Henrik Stenqvist | 16 |
| Matthew Gantz | 16 |
| Theresa Heggie | 16 |
| Kjell Rudolf Peter Edman | 14 |
| An van Es-Johansson | 13 |
| Birgitte Volck | 13 |
| Annika Muskantor | 11 |
| Hege Hellstrom | 11 |
| Cameron McDonough | 11 |
- Bourse
- Insiders
- Stephen James
- Connexions Sociétés
